TDT

TransDermal Technologies (TDT) is a specialty pharmaceutical company focused on the development and licensing of advanced transdermal delivery systems. The company's proprietary TDT platform utilizes a unique multi-component solvent system designed to transport a broad spectrum of active pharmaceutical ingredients—including small molecules, peptides, and large proteins—across the skin barrier and into the systemic circulation. By providing a non-invasive alternative to injections and oral medications, TDT aims to improve drug bioavailability, reduce systemic side effects, and enhance patient compliance. The company's pipeline includes transdermal formulations for pain management, dermatology, and metabolic disorders, often focusing on the repurposing of established therapeutic agents.